Dr. Adrian Lee:
Recruited to the University of Pittsburgh nearly a decade ago, Dr. Adrian Lee is director of the Institute for Precision Medicine (IPM), a joint effort by UPMC and the University of Pittsburgh to move biomedical research into personalized well-being and clinical care. He also is a professor of pharmacology and chemical biology and a professor of human genetics. In his own laboratory, Lee and his team are seeking to translate basic cell and molecular research findings into the understanding and treatment of breast cancer. Currently, he is leading an effort to sequence metastatic breast cancers to identify vulnerabilities for novel precision therapies.
As he describes his team’s work, “We are taking a comprehensive systems biology approach to discover how each breast cancer patient can receive treatments and therapies targeted to their specific biology and disease.”
Educated in England, Lee earned a bachelor’s degree in biochemistry from the University of Kent, Canterbury, Kent, England, and a Ph.D. at the University of Surrey, Guildford, Surrey, England. He completed a postdoctoral fellowship at the University of Texas Health Science Center in San Antonio, Texas. He has published more than 120 peer-reviewed research articles and serves on the scientific advisory council for Susan G. Komen for the Cure and on a number of national peer-review committees, as well as on the editorial boards of several scientific journals.